The application of transgenic and knockout mouse technology for the study of viral pathogenesis

Virology

Volumn 271, Issue 2, 2000, Pages 220-226

  Rall, Glenn F ^a   Lawrence, Diane M P ^a   Patterson, Catherine E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RECEPTOR;

AUTOIMMUNITY; BIOTECHNOLOGY; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; KNOCKOUT MOUSE; MEASLES; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; POLIOMYELITIS; PRIORITY JOURNAL; SHORT SURVEY; TRANSGENIC MOUSE; VIRUS EXPRESSION; VIRUS GENE; VIRUS GENOME; VIRUS PATHOGENESIS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMARY TUMOR ONCOVIRUS; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS; ONCOVIRINAE;

EID: 0034608196     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0337     Document Type: Article

References (43)

1. Akwa Y., Hassett D. E., Eloranta M. L., Sandberg K., Masliah E., Powell H., Whitton J. L., Bloom F. E., Campbell I. L. Transgenic expression of IFN-gamma in the CNS of mice protects against lethal neurotropic viral infection, but induces inflammation and neurodegeneration. J. Immunol. 161:1998;5016-5026.
2. Arita M., Ohka S., Sasaki Y., Nomoto A. Multiple pathways for establishment of poliovirus infection. Virus Res. 62:1999;97-105.
3. Browning J., Horner J. W., Pettoello-Mantovani M., Raker C., Yurasov S., DePinho R. A., Goldstein H. Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc. Natl. Acad. Sci. USA. 94:1997;14637-14641.
4. Deatly A. M., Coleman J. W., McMullen G., McAuliffe J. M., Jayarama V., Cupo A., Crowley J. C., McWilliams T., Taffs R. E. Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice. Virology. 255:1999;221-227.
5. Evans C. F., Horwitz M. S., Hobbs M. V., Oldstone M. B. A. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J. Exp. Med. 184:1996;2371-2384.
6. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor: Functional cDNA cloning of a seven transmembrane G protein-coupled receptor. Science. 272:1996;872-877.
7. Furth P. A. SV40 rodent tumor models as paradigms of human disease: Transgenic mouse models. Dev. Biol. Standard. 94:1998;281-287.
8. Gromeier M., Bossert B., Arita M., Nomoto A., Wimmer E. Dual stem loops within the poliovirus internal ribosome entry site control neurovirulence. J. Virol. 73:1999;958-964.
9. Guidotti L. G., Ando K., Hobbs M. V., Ishikawa T., Runkel L., Schreiber R. D., Chisari F. V. CTL inhibit HBV gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA. 91:1994;3764-3768.
10. Guidotti L. G., Borrow P., Hobbs M. V., Matzke B., Gresser I., Oldstone M. B. A., Chisari F. V. Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. USA. 93:1996;4589-4594.
11. Guidotti L. G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F. V. Viral clearance without destruction of infected cells during acute HBV infection. Science. 284:1999;825-829.
12. Horvat B., Rivailler P., Varior-Krishnan C., Cardoso A., Gerlier D., Robourdin-Combe C. Transgenic mice expressing human MV receptor CD46 provide cells exhibiting different permissivities to MV infection. J. Virol. 70:1996;6673-6681.
13. Huber S. A., Stone J. E., Wagner D. H., Kupperman J., Pfieffer L., David C., O'Brien R. L., Davis G. S., Newell M. K. Gamma-delta T cells regulate MHC class II (IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis. J. Virol. 73:1999;5630-5636.
14. Kagi D., Liedermann B., Burki K., Seller P., Odermatt B., Olsen K. J., Podack E., Zinkernagel R., Hengartner H. Cytotoxicity mediated by T cells and NK cells is greatly impaired in perforin-deficient mice. Nature. 369:1994;31-37.
15. Koike S., Taya C., Kurata T., Abe S., Ise I., Yonekawa H., Nomoto S. Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. USA. 88:1991;951-955.
16. Larkin J., Clayton M., Sun B., Perchonock C. E., Morgan J. L., Siracusa L. D., Michaels F. H., Fietelson M. A. Hepatitis B virus transgenic mouse model of chronic liver disease. Nat. Med. 5:1999;907-912.
17. Lawrence D. M. P., Patterson C. E., Gales T. L., D'Orazio J. L., Vaughn M. M., Rall G. F. Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation or extracellular virus production. J. Virol. 74:2000;1908-1918.
18. Lawrence D. M. P., Vaughn M. M., Belman A. R., Cole J. S., Rall G. F. Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and CNS disease. J. Virol. 73:1999;1795-1801.
19. Manchester M., Eto D. S., Oldstone M. B. A. Characterization of the inflammatory response during acute measles encephalitis in NSE-CD46 transgenic mice. J. Neuroimmunol. 96:1999;207-217.
20. Marshall D. C., Wyss-Coray T., Abraham C. R. Induction of matrix metalloproteinase-2 in HIV-1 gp120 transgenic mouse brains. Neurosci. Lett. 254:1998;97-100.
21. Minor P. D. Poliovirus. Nathanson N. Viral Pathogenesis. 1996;555-574 Lippincott-Raven, Philadelphia.
22. Mrkic B., Pavlovic J., Ulicke T. R., Volpe P., Buchholz C. J., Hourcade D., Atkinson J. P., Aguzzi A., Cattaneo R. Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72:1998;7420-7427.
23. Ohashi P. S., Oehen S., Buerki K., Pircher M., Ohashi C. T., Odermatt B., Malissen B., Zinkernagel R. M., Hengartner H. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:1991;305-317.
24. Ohka S., Yang W. X., Terada E., Iwasaki K., Nomoto A. Retrograde transport of intact poliovirus through the axon via fast axonal transport system. Virology. 250:1998;67-75.
25. Oldstone M. B. A. Molecular mimicry and immune-mediated disease. FASEB J. 12:1998;1255-1265.
26. Oldstone M. B. A., Lewicki H., Thomas D., Tishon A., Dales S., Patterson J., Manchester M., Homann D., Naniche D., Holz A. Measles virus infection in a transgenic model: Virus-induced immunosuppression and central nervous system disease. Cell. 98:1999;629-640.
27. Oldstone M. B. A., Nerenberg M., Southern P., Price J., Lewicki H. Virus infection triggers insulin dependent diabetes mellitus in a transgenic model: Role of anti self (virus) immune response. Cell. 65:1991;319-331.
28. Oxenius A., Bachmann M. F., Zinkernagel R. M., Hengartner H. Virus-specific MHC class II restricted TCR transgenic mice: Effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28:1998;390-400.
29. Qin W., Golovkina T. V., Peng T., Nepomnaschy I., Buggiano V., Piazzon I., Ross S. R. Mammary gland expression of mouse mammary tumor virus is regulated by a novel element in the long terminal repeat. J. Virol. 73:1999;368-376.
30. Raferty M. J., Behrens C. K., Muller A., Krammer P. H., Walczak H., Schonrich G. Herpes simplex virus type I infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion. J. Exp. Med. 190:1999;1103-1114.
31. Rall G. F., Manchester M., Daniels L. R., Callahan E. M., Belman A. R., Oldstone M. B. A. A transgenic mouse model for measles virus infection of the brain. Proc. Natl. Acad. Sci. USA. 94:1997;4659-4663.
32. Rall G. F., Oldstone M. B. A. Transgenic and knockout models of viral pathogenesis. Nathanson N. Viral Pathogenesis. 1996;507-531 Raven Press, New York.
33. Ren R., Costantini F., Gorgacz E. J., Lee J. J., Racaniello V. R. Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis. Cell. 63:1990;353-362.
34. Shiroki K., Ishii T., Aoki T., Ota Y., Yang W. X., Komatsu T., Ami Y., Arita M., Abe S., Hashizume S., Nomoto A. Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA. J. Virol. 71:1997;1-8.
35. Sigal L. J., Crotty S., Andino R., Rock K. L. Cytotoxic T cell immunity to virus-infected non-hematopoietic cells requires presentation of exogenous antigen. Nature. 398:1999;77-80.
36. Toggas S. M., Masliah E., Rockenstein E. M., Rall G. F., Abraham C. R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 367:1994;188-193.
37. Tsui L. V., Guidotti L. G., Ishikawa T., Chisari F. V. Post-transcriptional clearance of hepatitis B virus RNA by CTL-activated hepatocytes. Proc. Natl. Acad. Sci. USA. 92:1995;12398-12402.
38. Usherwood E. J., Brooks J. W., Sarawar S. R., Cardin R. D., Young W. D., Allen D. J., Doherty P. C., Nash A. A. Immunological control of murine gammaherpesvirus infection is independent of perforin. J. Gen. Virol. 78:1997;2025-2030.
39. von Herrath M. G., Evans C. F., Horwitz M. S., Oldstone M. B. A. Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system. Immunol. Rev. 152:1996;111-143.
40. Wakita T., Taya C., Katsume A., Kato J., Yonekawa H., Kanegae Y., Saito I., Hayashi Y., Koike M., Kohara M. Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the cre/loxP system. J. Biol. Chem. 273:1998;9001-9006.
41. Wilson J. B., Bell J. L., Levine A. J. Expression of Epstein-Barr virus nuclear antigen-1 (EBNA-1) induces B cell neoplasia in transgenic mice. EMBO J. 15:1996;3117-3126.
42. Zhang S., Racaniello V. R. Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut. J. Virol. 71:1997;4915-4920.
43. Zhou Z. S., Granucci F., Yeh L., Schaffer P. A., Cantor H. Molecular mimicry by herpes simplex virus type I: Autoimmune disease after viral infection. Science. 279:1998;1344-1347.